--------------------
explain
hemoconcentration
Thrombosed
AVFs
AVGs
AVGs
AVFs
--------------------
human
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
--------------------
create
AVGs
AVFs
rheolytic
AVGs
AVFs
--------------------
continue
AVGs
AVFs
rheolytic
AVGs
AVFs
--------------------
human
disease-2019
78%.5
CSDH)8
--------------------
create
disease-2019
--------------------
explain
--------------------
continue
disease-2019
--------------------
human
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
--------------------
continue
adenosinergic
Adenosinergic
eADO
eADO
Adenosinergic
ectonucleotidase
CD39
CD73
eATP
eADO
Adenosinergic
adenosinergic
eADO
indoleamine
Adenosinergic
ectonucleotidases
eATP
eADO
eATP
eADO
adenosinergic
adenosinergic
--------------------
create
Adenosinergic
Microenvironment
adenosinergic
eADO
eATP
eATP
eADO
eATP
eADO
adenosinergic
adenosinergic
eATP
eADO
adenosinergic
--------------------
explain
eATP
immunoregulation
eATP
eATP
eATP
eATP
eADO
ectonucleotidases
eADO
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
CD203a
eADO
eADO
eADO
CD73
eADO
--------------------
human
REF]).Detailed
sarcopenic
--------------------
explain
sarcopenic
sarcopenic
--------------------
create
Jentoft
Jentoft
Tanprasertsuk
AgeiNg
ENHANce
ENHANce
sarcopenic
ENHANce
--------------------
continue
ENHANce
aLM
aLM
SarQoL
--------------------
human
PASC.The
https://recovercovid.org/protocols
PASC.The
--------------------
continue
microthrombi
immunopathological
dysregulations
--------------------
explain
--------------------
create
immunopathological
AVFs
hemoconcentration
Thrombi
Thrombectomy
AVFs
AVGs
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
AVGs
AVFs
AVGs
AVFs
AVGs
AVFs
AVGs
AVFs
AVGs
AVFs
dialytic
AVGs
AVFs
rheolytic
AVGs
AVFs
rheolytic
microblades
stenosed
disease-2019
78%.5
CSDH)8
disease-2019
,that
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
ADPR
CD203a
ADPR
CD73
eADO
CD73
TNAP
adenosinergic
eADO
eATP
eATP
eATP
eATP
eATP
eADO
ectonucleotidases
immunosurveillance
eATP
adenosinergic
ectonucleotidases
eADO
ectonucleotidases
eATP
adenosinergic
eATP
eADO
adenosinergic
adenosinergic
eADO
eADO
eATP
eATP
eADO
adenosinergic
eATO
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
adenosinergic
eATP
eATP
eATP
eATP
eADO
ectonucleotidases
eADO
eATP
CD39
ectonucleoside
diphosphohydrolase
eATP
CD73
5′-nucleotidase
eADO
ectohydrolase
CD203a
ectonucleotide
eADO
CD203a
eADO
CD73
eADO
eADO
CD39
CD73
CD73
eADO
eADO
REF]).Detailed
sarcopenic
sarcopenic
sarcopenic
sarcopenic
sarcopenic
sarcopenic
Jentoft
ENHANce
ENHANce
sarcopenic
AgeiNg
ENHANce
sarcopenic
aLM
aLM
SarQoL
sarcopenic
PASC.The
https://recovercovid.org/protocols
PASC.The
IL)-6
hyperinflammatory
immunopathological
Biospecimens
thrombogenic
immunopathological
IL)-1β
immunopathological
